Use your antibodies-online credentials, if available.
Il n’y a pas de produits dans votre liste de comparaison.
Votre panier est vide.
The RAS oncogene (MIM 190020) is mutated in nearly one-third of all human cancers. De plus, nous expédions RASSF3 Protéines (7) et beaucoup plus de produits pour cette protéine.
Showing 10 out of 64 products:
Polyclonal RASSF3 Primary Antibody pour ELISA, WB - ABIN539821
Tommasi, Dammann, Jin, Zhang, Avruch, Pfeifer: RASSF3 and NORE1: identification and cloning of two human homologues of the putative tumor suppressor gene RASSF1. dans Oncogene 2002
low expression is associated with malignant phenotypes in non-small cell lung cancer patients
Taken together, these findings indicate that the RASSF3 promoter rs6581580 T>G SNP is potentially functional, modulating susceptibility to SCCHN among non-Hispanic whites.
hypermethylation-induced RASSF3 silencing plays an important role in the tumorigenesis of pituitary somatotroph adenomas.
tumor suppressor activity of RASSF3, which occurs through p53 stabilization and regulation of apoptosis and the cell cycle.
Mammary tumor incidence in bi-transgenic mice is delayed, suggesting that transgenic Rassf3 may influence mammary tumor incidence in transgenic mice
The presence of a Ras association domain common to NORE1,RASSF1, and RASSF3 suggests their possible involvement inRas-like signaling pathways.
The RAS oncogene (MIM 190020) is mutated in nearly one-third of all human cancers. Members of the RAS superfamily are plasma membrane GTP-binding proteins that modulate intracellular signal transduction pathways. A subfamily of RAS effectors, including RASSF3, share a RAS association (RA) domain.
Ras association (RalGDS/AF-6) domain family member 5
, Ras association (RalGDS/AF-6) domain family member 3
, Ras association (RalGDS/AF-6) domain family 3
, Ras association (RalGDS/AF-6) domain family 5
, ras association domain-containing protein 3
, Ras association domain family 3
, novel ras effector 1